Michelle Allison
Psychiatric/Mental Health · Gaffney, SCNPI 1578930574
Payments from drug & device makers
Across 144 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$430
- Teva Pharmaceuticals USA, Inc.$360
- Otsuka America Pharmaceutical, Inc.$258
- Johnson & Johnson$229
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$223
- Vanda Pharmaceuticals Inc.$216
- plus $653 from 8 others
What the payments were for
- Food & beverage$2,22094%
- Education$1486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $430 |
| Teva Pharmaceuticals USA, Inc. | 16 | $360 |
| Otsuka America Pharmaceutical, Inc. | 19 | $258 |
| Johnson & Johnson | 13 | $229 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $223 |
| Vanda Pharmaceuticals Inc. | 10 | $216 |
| Neurocrine Biosciences, Inc. | 8 | $180 |
| E.r. Squibb & Sons, L.L.C. | 5 | $109 |
| Indivior Inc. | 8 | $108 |
| Alkermes, Inc. | 4 | $63 |
| Lundbeck LLC | 3 | $62 |
| Corium, LLC | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
How this compares
$2,368 in reported general payments places this provider in the 75th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 30 | $100,972 |
| Abilify MaintenaAripiprazole | 21 | $63,062 |
| VraylarCariprazine Hcl | 12 | $17,454 |
| Paliperidone ErPaliperidone | 21 | $2,763 |
| Risperidone OdtRisperidone | 15 | $2,246 |
| Haloperidol Decanoate | 14 | $1,008 |
| Lurasidone Hcl | 23 | $711 |
| Aripiprazole | 37 | $663 |
| Buspirone Hcl | 45 | $632 |
| Divalproex Sodium | 16 | $552 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $531 |
| Benztropine Mesylate | 28 | $528 |
| Trazodone Hcl | 95 | $471 |
| Hydroxyzine Pamoate | 43 | $460 |
| Quetiapine Fumarate | 38 | $369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $229 | $100,97230 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $258 | $63,06221 claims |
| AbbVieVraylar | $430 | $17,45412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Gaffney
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Cerrissa HugieCharleston$54K
- Karen FulwoodMyrtle Beach$30K
- Taylor CrewsIsle Of Palms$28K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- Mary McManusNorth Myrtle Beach$15K
- Kelsie FowlerAnderson$15K
- William HendricksGreenville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.